| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |